MAOA and Parkinson disease: A plethora of data is available regarding the effect of clorgyline, a MAO-A specific inhibitor on mammalian cells due to its effectiveness in the treatment of neurological diseases such as Alzheimer’s and Parkinson’s disease as well as in the treatment of clinical depression.